Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat

Drugmakers are urging the Trump administration and EU officials to exclude medical goods from expanding tariff wars.

They want to avert price spikes on top-selling medicines made in Europe from Novo Nordisk's Wegovy for weight loss to Merck's cancer immunotherapy Keytruda.